ConductScience.org, home

Paper61862

Pharmacokinetic analysis of the interaction between dicoumarol and tolbutamide in man.

Jähnchen E and 3 others. Eur J Clin Pharmacol, 1976. Cited by 9 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pharmacokinetic analysis of the interaction between dicoumarol and tolbutamide in man. Papers, record 61862. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/61862

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetic analysis of the interaction between dicoumarol and tolbutamide in man.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.46
iCite
Revised in PubMed
2019-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jähnchen EE
2Meinertz TT
3Gilfrich HJH J
4Groth UU

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DicumarolMajor topic
TolbutamideMajor topic
Adult
Drug Interactions
Half-Life
Humans
Male
Protein Binding

Source PubMed

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,154,932A method for computing active drug from plasma levels in cases of multiple binding.Comput Programs Biomed1971https://conductscience.org/library/papers/5154932PubMed
24,172,323Comparative pharmacokinetics of coumarin anticoagulants. I. Unusual interaction of bishydroxycoumarin with plasma proteins--development of a new assay.J Pharm Sci1968https://conductscience.org/library/papers/4172323PubMed
55,445,741Parmacokinetic analysis of the effect of barbiturate on the anticoagulant action of warfarin in man.Clin Pharmacol Ther1970https://conductscience.org/library/papers/5445741PubMed
64,168,588Effect of phenyramidol and bishydroxycoumarin on the metabolism of tolbutamide in human subjects.Metabolism1967https://conductscience.org/library/papers/4168588PubMed
85,696,001[Quantitative determination of protein binding of drugs by gel filtration].Arzneimittelforschung1968https://conductscience.org/library/papers/5696001PubMed
94,192,280Kinetics of the anticoagulant effect of bishydroxycoumarin in man.Clin Pharmacol Ther1970https://conductscience.org/library/papers/4192280PubMed
104,164,590Potentiation of the tolbutamide effect by dicoumarol.Diabetes1967https://conductscience.org/library/papers/4164590PubMed
114,397,794Drug interactions with coumarin anticoagulants. 2.N Engl J Med1971https://conductscience.org/library/papers/4397794PubMed
125,968,015The metabolic fate of tolbutamide in man and in the rat.J Med Chem1966https://conductscience.org/library/papers/5968015PubMed
1314,219,503PROTRACTED TOLBUTAMIDE-INDUCED HYPOGLYCEMIA.Arch Intern Med1965https://conductscience.org/library/papers/14219503PubMed
145,765,183Kinetics of pharmacologic effects in man: the anticoagulant action of warfarin.Clin Pharmacol Ther1969https://conductscience.org/library/papers/5765183PubMed
1514,167,102STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: A COMPARISON OF THE PHARMACODYNAMICS OF DICUMAROL AND WARFARIN IN MAN.Thromb Diath Haemorrh1964https://conductscience.org/library/papers/14167102PubMed
164,162,027Absence of tolbutamide effect on anticoagulant therapy.JAMA1966https://conductscience.org/library/papers/4162027PubMed
174,129,954Relationship between distribution, elimination and anticoagulant action of dicumarol.J Pharmacol Exp Ther1974https://conductscience.org/library/papers/4129954PubMed
184,186,901An experimental model in dogs for studying interactions of drugs with bishydroxycoumarin.Clin Pharmacol Ther1969https://conductscience.org/library/papers/4186901PubMed

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
7,741,982Antihyperglycaemic agents. Drug interactions of clinical importance.Drug Saf1995https://conductscience.org/library/papers/7741982PubMed
7,431,221Effect of serum protein binding on pharmacokinetics and anticoagulant activity of phenprocoumon in rats.J Pharmacokinet Biopharm1980https://conductscience.org/library/papers/7431221PubMed
1,932,962Warfarin potentiated by proguanil.BMJ1991https://conductscience.org/library/papers/1932962PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/61862

GET https://conductscience.org/api/papers/v1/61862/authors